Market News Today In Vitro Diagnostics Market | Page 3

Regional Insight
North America was the major region and is expected to grow owing to incidence of chronic disorders
which includes respiratory diseases and cancer in this region. Europe was estimated at over USD 23.92
billion in 2016 and is predicted to rise due to growing prevalence rate of cancer, tuberculosis and
pneumonia in the coming years.
Asia Pacific is followed by Europe, which accounted for over 21.0% of market share in 2016. Growing
clinical research, government initiatives in order to enhance the diagnostics with the increasing per
capita healthcare expenditure will help to promote the growth over the forecast period.
The IVD majorly adds to the health and wellbeing of the European economy. Over 40,000 IVD products
are available in the market which caters to the needs of specialists and patients for a wide array of
conditions.
Competitive Insights
Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostics, Abbott
Laboratories, and Beckman Coulter Inc. are the key players of the market. These players provide
different solutions such as various required services, reagents, and instruments. The companies are
occupied in wide R&D activities to gain sustainability and commercialize new products in this segment
which is expected to increase the market rivalry.
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/healthcare
In April 2015, Abbott and Sekisui declared a conformity to offer around the globe coagulation testing
solutions. As per the conformity, the elite distributor is Abbott of CP3000 coagulation instrument
(Sekisui), in Europe, the U.S., and regions that approve CE mark.
In December 2014, the product line was expanded by Roche for testing of human tissue and organ
for next-generation blood screening assays. Cobas MPX and cobas WNX assays were introduced for
usage in human organ and tissue testing, hence growing the range of permitted uses for the cobas
6800/8800 assays and systems